| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
RESEARCH |
1 Colorado Center for Reproductive Medicine, 799 East Hampden Avenue, Englewood, CO 80113, USA2 Department of Biomedical Sciences, Colorado State University, Fort Collins, CO 80523-1683, USA
Correspondence should be addressed to D K Gardner; Email: dgardner{at}colocrm.com
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Understanding energy substrate metabolism of the oocyte throughout in vitro-maturation may aid in optimizing maturation conditions. Energy requirements of the cumulusoocyte complex (COC) are unique, as the cumulus cells and oocyte have different metabolic needs. Denuded mouse oocytes require pyruvate or oxaloacetate in the medium in order to mature, whereas COCs develop in medium containing lactate, phosphoenolpyruvate, or glucose (Biggers et al. 1967). Cumulus cells metabolize alternative substrates, such as glucose, which ultimately produce substrates that the oocyte requires for maturation.
Metabolism has been assessed in the mouse oocyte by several groups; however, experimental designs allowed for only a single time-point measurement of individual oocytes (Roberts et al. 2004) or multiple measurements throughout maturation using groups of oocytes, thus making correlation with meiotic status and subsequent embryo development difficult (Downs et al. 2002). Additionally, oocytes used in most studies were collected from mice primed with exogenous gonadotropins, which may alter the metabolic profile of the recovered oocytes (Downs et al. 1996, Fagbohun & Downs 1992). Oocytes recovered from mice primed with equine chorionic gonadotropin (eCG) have higher maturation, two-cell and blastocyst rates (De La Fuente et al. 1999). However, ovarian stimulation in mice has been associated with delayed embryonic development, fetal growth retardation, and increased fetal loss (Edwards et al. 2004, Ertzeid & Storeng 2001, Van der Auwera & DHooghe 2001). Supplementation of maturation medium with FSH has varying effects on oocyte developmental competence based on age of donor mice and in vivo priming with gonadotropins. After in vitro maturation in the presence of FSH, oocytes collected from primed 2224-day-old mice displayed increased developmental competence (Downs et al. 1986). However, in older mice (26 days) FSH supplementation in the maturation medium produced improved developmental competence only in oocytes collected from unprimed mice, with no effect seen in oocytes collected from primed mice (Eppig et al. 1992). Additionally, when gonadotropins are supplemented in the maturation medium of oocytes recovered from both primed and unprimed mice, the metabolic profiles differ between groups. When immature oocytes were collected from unprimed mice and subsequently matured with or without FSH, the FSH groups had higher glucose uptake and higher production of both lactate and pyruvate (Roberts et al. 2004). In addition to altering carbohydrate uptake and production, maturation in the presence of FSH changes substrate metabolism. COCs principally metabolize glucose via glycolysis, and the addition of FSH in the medium increases glycolysis 2.7-fold (Downs and Utecht 1999). Futhermore, supplementation of FSH into maturation medium induced aneuploidy in in vitro-matured mouse oocytes (Roberts et al. 2005).
In addition to assisting medium optimization, metabolic profiles may also serve as a potential marker of oocyte viability. Oocyte morphology is often used as a predictor of development; however, this is not a very accurate method of selection. Nuclear and cytoplasmic maturation are often asynchronous. Cytoplasmic maturation is required for activation of the oocyte at fertilization and subsequent embryo development. The oocytes cytoplasm provides the appropriate metabolic machinery for production of energy for cellular functions during maturation, fertilization, and embryo development. Metabolic profiles of mouse embryos have been established as valuable indicators of embryo viability (Gardner & Leese 1987, Lane & Gardner 1996). The use of noninvasive metabolic assays would quantify oocyte characteristics and potentially result in a method of predicting developmentally competent oocytes.
The metabolic profiles of individual mouse oocytes throughout maturation have not been studied in the unstimulated mouse. The first objective of this study was to characterize the metabolic profile of the individual oocyte throughout maturation. Three categories of oocytes were included: COCs, denuded oocytes, and denuded oocytes matured in the presence of cumulus cells. The second objective was to compare metabolic profiles of COCs that matured and fertilized versus COCs that exhibited nuclear maturation, but failed to fertilize.
| Materials and Methods |
|---|
|
|
|---|
Assessment of oocyte metabolism
Oocytes (n = 604) were matured in one of nine treatment groups (Fig. 1
). A minimum of 50 oocytes were matured in each group. Group 1 was matured with cumulus cells intact throughout maturation (017 h). Cumulus cells were removed from remaining groups at various intervals, and stripped oocytes were matured with or without the presence of cumulus cells. Groups 2, 3, 4, and 5 were denuded at 12, 8, 4, and 0 h respectively, and subsequently matured with no cumulus cells. Groups 6, 7, 8, and 9 were denuded at 12, 8, 4, and 0 h respectively, and their cumulus cells were replaced into the medium for the duration of maturation. Oocytes were denuded in G-MOPS with 1 mg/ml hyaluronidase. Oocytes and cumulus cells were rinsed three or four times in the defined maturation medium prior to incubation. Control oocytes (COCs, denuded, and denuded plus cumulus) were matured individually in 5 µl drops and remained undisturbed in the incubator until 17 h of maturation. Fertilization and embryo culture of control oocytes were identical to treatment oocytes.
|
Cumulus cell counts
COCs (n = 56) were denuded upon removal from the follicle and divided into four groups. Denuded oocytes were matured with their cumulus cells in 0.5 µl drops of medium, with a medium change over every 4 h as described above. In group 1, cumulus cells were stained and counted following a 4 h maturation interval. Cumulus cells in groups 2, 3, and 4 were stained following 8, 12, and 16 h of maturation, respectively. For staining, cumulus cells from individual oocytes were placed into Triton X-100 for 45 s and then placed into a 20 µl drop of propidium iodide for a minimum of 5 min. Cells for individual oocytes were counted and cumulus cell numbers from the same group were averaged.
Experiment 2: Assessment of glucose metabolism at 812 h maturation for COCs that fertilized versus COCs that matured and failed to fertilize
COCs (n = 59) were matured in 5 µl drops of medium until 8 h. At 8 h, oocytes were transferred into 0.5 µl drops for 4 h. Following the 4 h incubation, oocytes were transferred back into the original 5 µl drops of maturation medium until 17 h. Oocytes were then fertilized, and presumptive zygotes and embryos were cultured for 96 h. Medium drops from the 4 h incubation were frozen and stored for glucose analysis.
Experiment 3: Assessment of lactate production at 816 h maturation for COCs that fertilized versus COCs that matured and failed to fertilize
COCs were matured in 5 µl drops of medium until 8 or 12 h. At 8 h (n = 30) or 12 h (n = 44), oocytes were transferred into 0.5 µl drops for 4 h. Following the 4 h incubation, oocytes were transferred back into the original 5 µl drops of maturation medium until 17 h. Oocytes were then fertilized, and presumptive zygotes and embryos were cultured for 96 h. Medium drops from the 4 h incubation were frozen and stored for lactate analysis.
Statistical analysis
Preplanned comparisons of maturation and fertilization rates between specific treatment groups were compared using Fishers exact test. Metabolic profiles were analyzed by one-way analysis of variance or by KruskalWallis test, in cases where variances were heterogeneous. Cumulus cell numbers were analyzed by one-way analysis of variance. Comparisons between metabolic profiles of fertilized and unfertilized oocytes (experiments 2 and 3) were done by Students t-test.
| Results |
|---|
|
|
|---|
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Blastocyst development was lower in this study compared with other studies for several reasons. First, oocytes and embryos were matured and cultured individually as opposed to groups. Oocytes and embryos in groups may benefit from the sharing of paracrine factors among one another, potentially enhancing developmental competence. Second, the high level of oocyte manipulation throughout the course of in vitro maturation could have resulted in reduced developmental rates. Finally, the literature has reported a wide range of blastocyst development from in vitro-matured mouse oocytes, with higher percentages of blastocysts being produced from protocols including in vivo gonadotropin priming and/or inclusion of FSH in the maturation medium (Eppig et al. 1992, Merriman et al. 1998, Schroeder et al. 1988).
Throughout maturation change-overs took place every 4 h. Numbers of cumulus cells in group 9 decreased over time. Previous estimates of the number of cumulus cells surrounding an individual mouse oocyte averaged 2060 cells (Leese & Barton 1985). The average number of cells initially placed with each oocyte was 1200. During the maturation process some cells plated to the dish, preventing transfer to the subsequent medium drop. Loss in cumulus cells affected metabolic analysis, perhaps leading to the differences between the COC and the denuded group matured with cumulus cells during the last 8 h of maturation. Additionally, cumulus cells decrease glucose oxidation once removed from the oocyte (Zuelke & Brackett 1992). Both of these factors would influence the metabolic profile of this group of oocytes and may account for the differences between the COC group.
This study shows that the metabolic profile of developmentally competent oocytes changes throughout maturation. Metabolic activity of COCs increased toward the end of maturation. It is important to acknowledge that the maturation conditions and medium, as well as the source of the oocytes (primed versus unprimed mice), will affect metabolism of the oocyte. Under the present conditions of maturation in a defined system, the beginning hours of maturation are relatively quiescent, and towards 11 h of maturation the COC increases in metabolic activity. The increased uptake and production of nutrients by the COC during this time may reflect the need to support various processes associated with completion of both nuclear and cytoplasmic maturation. As stated above, a change in the maturation conditions may result in changes in the metabolic profile. For example, FSH-primed mice or oocytes matured in the presence of FSH may show an increase in metabolism at an earlier time point in the maturation process, as oocytes matured in the presence of FSH reach maturation sooner than non-FSH-treated oocytes (Roberts et al. 2004). In future studies, the use of this defined maturation system will allow for changes in medium composition, such as the addition of FSH and/or LH, to be directly correlated to changes in oocyte metabolism and developmental potential.
In the present study, metabolic activity of oocytes during later stages of maturation correlated with developmental competence of in vitro matured COCs. Few groups have examined the relationship between metabolism, oocyte maturation, and developmental competence. In the mouse, COCs progressing through meiosis and denuded oocytes have a greater requirement for pyruvate than prophase I- or MII-arrested oocytes (Downs et al. 2002). Higher rates of glycolysis by bovine oocytes denuded at the end of a 24-h maturation period were associated with increased developmental potential (Krisher & Bavister 1999). Blastocyst development in cats was also associated with higher rates of glycolysis by denuded oocytes; however, no correlation was determined between glycolytic activity or glucose oxidation by cumulus cells and subsequent oocyte development (Spindler et al. 2000). In the present study, COCs that were able to fertilize consumed more glucose and produced more lactate than the oocytes that failed to fertilize. This increase in metabolism may indicate healthier oocytes.
Lactate production increased in fertilized COCs throughout the maturation process, indicating an increase in glycolysis in the later half of maturation. During the first 12 h of maturation of COCs, approximately three-quarters of glucose is being converted to lactate, whereas during the final 4 h of maturation less than two-thirds of the glucose is being converted to lactate. However, actual glycolytic rates cannot be calculated from this study, as pyruvate was included in the maturation medium. Pyruvate in the medium could have been converted to lactate, thus artificially increasing the lactate production.
Synthesis of extracellular matrix by cumulus cells in the later stages of maturation leads to mucification and expansion of cumulus cells. It has been shown that the addition of glucosamine to medium reduces the total glucose uptake by bovine COCs during the final stages of maturation (Sutton-McDowall et al. 2004). When glucosamine is not included in the medium, as in the present study, a portion of glucose must be utilized in this pathway to produce the extracellular matrix component hyaluronic acid. The same phenomenon has been demonstrated in the mouse under FSH induction of meiosis (Salustri et al. 1989); however, in the present study no FSH was added to the medium, although EGF was included, which has also been shown to act on cumulus cells to trigger germinal vesicle breakdown (Downs et al. 1988, De La Fuente et al. 1999). Another route of glucose consumption that has been shown to play a large role in oocyte maturation is the pentose phosphate pathway (Downs & Utecht 1999, Downs et al. 1998). Towards the end of maturation, the increase flux of glucose though the pentose phosphate pathway allows increased production of substrates involved in nuclear maturation (Sutton et al. 2003). COCs that fertilized consumed a larger amount of glucose in the later half of maturation than those that did not fertilize, thus allowing these COCs to generate increased energy not only though glycolysis, but also through alternative biosynthetic pathways that yield products necessary for complete nuclear and cytoplasmic maturation.
In conclusion, developmental and metabolic data generated from this study have implications for both research and clinical settings. First, when COCs are denuded for procedures such as intracytoplasmic sperm injection and are found to be immature, they are sometimes placed back into maturation until they reach MII. The data from this study suggest that developmental competence will be enhanced when cumulus cells are placed in the medium with germinal vesicle (GV) or metaphase I-denuded oocytes. Second, metabolic data differed between COCs that subsequently fertilized and those COCs that matured but failed to fertilize. Not only did the glucose and lactate profiles of developmentally competent COCs change throughout maturation, but glucose uptake and lactate production were higher for oocytes that subsequently fertilized compared with those that failed to fertilize. Therefore, glucose and lactate profiles may provide a non-invasive measurement of oocyte viability. At this point, the overlap between COCs that fertilize and those that fail to fertilize does not allow this assessment to prospectively predict which oocytes will fertilize. However, the use of metabolic assessments would allow for COCs with higher glucose uptake and lactate production to be subsequently grouped together, allowing the healthier oocytes to benefit from shared paracrine factors. The use of metabolic markers, in conjunction with other established markers of oocyte viability, should facilitate improvements in the in vitro maturation system, allowing evaluations of in vitro-maturation systems to expand from solely morphological criteria to non-invasive quantitative assessment.
| Acknowledgements |
|---|
|
|
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Biggers J, Whittingham D & Donahue R 1967 The pattern of energy metabolism in the mouse oocyte and zygote. PNAS 58 560567.
Blondin P, Bousquet D, Twagiramungu H, Barnes F & Sirard MA 2002 Manipulation of follicular development to produce developmentally competent bovine oocytes. Biology of Reproduction 66 3843.
De La Fuente R, OBrien MJ & Eppig JJ 1999 Epidermal growth factor enhances preimplantation developmental competence of maturing mouse oocytes. Human Reproduction 14 30603068.
Downs SM & Utecht AM 1999 Metabolism of radiolabeled glucose by mouse oocytes and oocyte-cumulus cell complexes. Molecular Reproduction and Development 60 14461452.
Downs SM, Schroeder AC & Eppig JJ 1986 Developmental capacity of mouse oocytes following maintenance of meiotic arrest in vitro. Gamete Research 15 305316.[CrossRef][ISI]
Downs SM, Daniel SA & Eppig JJ 1988 Induction of maturation in cumulus cell-enclosed mouse oocytes by follicle-stimulating hormone and epidermal growth factor: evidence for a positive stimulus of somatic cell origin. Journal of Experimental Zoology 245 8691.
Downs SM, Humpherson PG, Marin KL & Leese HJ 1996 Glucose utilization during gonadotropin induced meiotic maturation in cumulus cell enclosed mouse oocytes. Molecular Reproduction and Development 44 121131.[CrossRef][ISI][Medline]
Downs SM, Humpherson PG & Leese HJ 1998 Meiotic induction of cumulus cell enclosed mouse oocytes: involvement of the pentose phosphate pathway. Biology of Reproduction 58 10841094.
Downs SM, Humpherson PG & Leese HJ 2002 Pyruvate utilization by mouse oocytes is influenced by meiotic status and the cumulus oophorus. Molecular Reproduction and Development 62 113123.[CrossRef][ISI][Medline]
Edwards LJ, Kind KL, Armstrong DT & Thompson JG 2004 The effects of recombinant human follicle stimulating hormone (rFH) on embryo development in mice. American Journal of Physiology Endocrinology and Metabolism 288 E845E851.
Eppig JJ, Schroeder AC & OBrien MJ 1992 Developmental capacity of mouse oocytes matured in vitro: effects of gonadotrophic stimulation, follicular origin and oocyte size. Journal of Reproduction and Fertility 95 119127.[Abstract]
Ertzeid G & Storeng R 2001 The impact of ovarian stimulation on implantation and fetal development in mice. Human Reproduction 16 221225.
Fagbohun CF & Downs SM 1992 Requirement for glucose in ligand stimulated meiotic maturation of cumulus cell enclosed mouse oocytes. Journal of Reproduction and Fertility 96 681697.[Abstract]
Fatehi A, Zeinstra E, Kooij R, Colenbrander B & Bevers M 2002 Effect of cumulus cell removal of in vitro matured bovine oocytes prior to in vitro fertilization on subsequent cleavage rate. Theriogenology 57 13471355.[CrossRef][ISI][Medline]
Gardner DK & Leese HJ 1987 Assessment of embryo viability prior to transfer by the noninvasive measurement of glucose uptake. Journal of Experimental Zoology 242 103105.
Gardner DK & Leese HJ 1990 Concentrations of nutrients in mouse oviduct fluid and their effects on embryo development and metabolism in vitro. Journal of Reproduction and Fertility 88 361368.[Abstract]
Gardner DK & Lane M 2004 Culture of the mammalian preimplantation embryo. In A Laboratory Guide to the Mammalian Embryo, pp 4161. Eds DK Gardner, M Lane & AJ Watson. New York: Oxford University Press.
Gardner DK, Lane M, Maybach JM & Hasler JF 2001 Bovine oocyte maturation in a completely defined medium: replacing serum with recombinant albumin and hyaluronan. Theriogenology 55 471.[CrossRef]
Gardner DK, Reed L, Linck D, Sheehan C & Lane M 2005 Quality control in human IVF. Seminars in Reproductive Medicine [in press].
Krisher RL 2004 The effect of oocyte quality on development. Journal of Animal Science 82 (E. Suppl.) E14E23.
Krisher RL & Bavister BD 1999 Enhanced glycolysis after maturation of bovine oocytes in vitro is associated with increased developmental competence. Molecular Reproduction and Development 53 1926.[CrossRef][ISI][Medline]
Lane M & Gardner DK 1996 Selection of viable mouse blastocysts prior to transfer using a metabolic criterion. Human Reproduction 11 19751978.
Lane M & Gardner DK 2004 Preparation of gametes, in vitro maturation, in vitro fertilization, and embryo recovery and transfer. In A Laboratory Guide to the Mammalian Embryo, pp 2440. Eds DK Gardner, M Lane & AJ Watson. New York: Oxford University Press.
Leese HJ & Barton AM 1984 Pyruvate and glucose uptake by mouse ova and preimplantation embryos. Journal of Reproduction and Fertility 72 913.[Abstract]
Leese HJ & Barton AM 1985 Production of pyruvate by isolated mouse cumulus cells. Journal of Experimental Zoology 234 231236.
Merriman JA, Whittingham DG & Carroll J 1998 The effect of follicle stimulating hormone and epidermal growth factor on the developmental capacity of in vitro matured mouse oocytes. Human Reproduction 13 690695.
Pincus G & Enzmann EV 1935 The comparative behavior of mammalian eggs in vivo and in vitro I. The activation of ovarian eggs. Journal of Experimental Medicine 62 665675.[Abstract]
Roberts R, Stark J, Iatropoulou A, Becker DL, Franks S & Hardy K 2004 Energy substrate metabolism of mouse cumulus oocyte complexes: Response to follicle stimulating hormone is mediated by the phosphatidylinositol 3-kinase pathway and is associated with oocyte maturation. Biology of Reproduction 71 199209.
Roberts R, Iatropoulou A, Ciantar D, Stark J, Becker DL, Franks S & Hardy K 2005 Follicle stimulating hormone affects metaphase I chromosome alignment and increases aneuploidy in mouse oocytes matured in vitro. Biology of Reproduction 72 107118.
Salustri A, Yanagishita M & Hascall VC 1989 Synthesis and accumulation of hyaluronic acid and proteoglycans in the mouse cumulus cell oocyte complex during follicle stimulating hormone induced mucification. Journal of Biological Chemistry 264 1384013847.
Schroeder AC & Eppig JJ 1984 The developmental capacity of mouse oocytes that matured spontaneously in vitro is normal. Developmental Biology 102 493497.[CrossRef][ISI][Medline]
Schroeder AC, Downs SM & Eppig JJ 1988 Factors affecting the developmental capacity of mouse oocytes undergoing maturation in vitro. Annals of the New York Academy of Sciences 541 197204.[ISI][Medline]
Spindler RE, Pukazhenthi BS & Wildt DE 2000 Oocyte metabolism predicts the development of cat embryos to blastocyst in vitro. Molecular Reproduction and Development 56 163171.[CrossRef][ISI][Medline]
Sutton ML, Cetica PD, Beconi MT, Kind KL, Gilchrist RB & Thompson JG 2003 Influence of oocyte-secreted factors and culture duration on the metabolic activity of bovine cumulus cell complexes. Reproduction 126 2734.[Abstract]
Sutton-McDowall ML, Gilchrist RB & Thompson JG 2004 Cumulus expansion and glucose utilisation by bovine cumulus-oocyte complexes during in vitro maturation: the influence of glucosamine and follicle stimulating hormone. Reproduction 128 313319.
Van de Leemput EE, Vos PL, Zeinstra EC, Bevers MM, van der Weijden GC & Dieleman SJ 1999 Improved in vitro embryo development using in vivo matured oocytes from heifers superovulated with a controlled preovulatory LH surge. Theriogenology 52 335349.[CrossRef][ISI][Medline]
Van der Auwera I & DHooghe T 2001 Superovualtion of female mice delays embryonic and fetal development. Human Reproduction 10 12371243.
Zhang I, Jiang J, Wozniak P, Yang X & Godke R 1995 Cumulus cell function during bovine oocyte maturation, fertilization, and embryo development in vitro. Molecular Reproduction and Development 40 338344.[CrossRef][ISI][Medline]
Zuelke K & Brackett B 1992 Effects of lutenizing hormone on glucose metabolism in cumulus enclosed bovine oocytes matured in vitro. Endocrinology 131 26902696.[Abstract]
This article has been cited by other articles:
![]() |
P. Zheng, R. Vassena, and K. E. Latham Effects of in vitro oocyte maturation and embryo culture on the expression of glucose transporters, glucose metabolism and insulin signaling genes in rhesus monkey oocytes and preimplantation embryos Mol. Hum. Reprod., June 1, 2007; 13(6): 361 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Russell and R. L. Robker Molecular mechanisms of ovulation: co-ordination through the cumulus complex Hum. Reprod. Update, May 1, 2007; 13(3): 289 - 312. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |